The action of mimetic peptides on connexins protects fibroblasts from the negative effects of ischemia reperfusion.

Autor:	Glass BJ; Department of Cell and Developmental Biology, University College London, Gower Street, London WC1E 6BT, UK., Hu RG; Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, Singapore 308232., Phillips AR; CoDa Therapeutics, Inc., 10 College Hill Road, Herne Bay, Auckland 1011, New Zealand School of Biological Sciences, University of Auckland, Auckland 1010, New Zealand., Becker DL; Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, Singapore 308232 david.becker@ntu.edu.sg.
Jazyk:	angličtina
Zdroj:	Biology open [Biol Open] 2015 Oct 15; Vol. 4 (11), pp. 1473-80. Date of Electronic Publication: 2015 Oct 15.
DOI:	10.1242/bio.013573
Abstrakt:	Connexins have been proposed as a target for therapeutic treatment of a variety of conditions. The main approaches have been by antisense or small peptides specific against connexins. Some of these peptides enhance communication while others interfere with connexin binding partners or bind to the intracellular and extracellular loops of connexins. Here, we explored the mechanism of action of a connexin mimetic peptide by evaluating its effect on gap junction channels, connexin protein levels and hemichannel activity in fibroblast cells under normal conditions and following ischemia reperfusion injury which elevates Cx43 levels, increases hemichannel activity and causes cell death. Our results showed that the effects of the mimetic peptide were concentration-dependent. High concentrations (100-300 μM) significantly reduced Cx43 protein levels and GJIC within 2 h, while these effects did not appear until 6 h when using lower concentrations (10-30 μM). Cell death can be reduced when hemichannel opening and GJIC were minimised. (© 2015. Published by The Company of Biologists Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu